Treatment of patients with myocardial infarction depends on history of cancer

Background: Although cancer treatment considerably affects cardiovascular health, little is known about how cancer patients are treated for an acute myocardial infarction. We aimed to investigate whether acute myocardial infarction patients with a history of cancer received the same guideline recommended treatment as those acute myocardial infarction patients without and whether they differ with respect to inhospital outcome. Methods: All patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction, enrolled between 2002 and mid-2015 in the acute myocardial infarction in Switzerland (AMIS Plus) registry with comorbidity data based on the Charlson comorbidity index were analysed. Patients were classified as having cancer if one of the cancer diseases of the Charlson comorbidity index was indicated. Immediate treatment strategies and inhospital outcomes were compared between groups using propensity score matching. Results: Of 35,249 patients, 1981 (5.6%) had a history of cancer. After propensity score matching for age, gender, Killip class >2, ST-segment elevation myocardial infarction and renal disease (1981 patients per group), significant differences were no longer found for a history of acute myocardial infarction, hypertension, diabetes, heart failure and cerebrovascular disease between cancer and non-cancer patients. However, cancer patients underwent percutaneous coronary intervention less frequently (odds ratio (OR) 0.76; 95% confidence interval (CI) 0.67–0.88) and received P2Y12 blockers (OR 0.82; 95% CI 0.71–0.94) and statins (OR 0.87; 95% CI 0.76–0.99) less frequently. Inhospital mortality was significantly higher in cancer patients (10.7% vs. 7.6%, OR 1.45; 95% CI 1.17–1.81). However, the main cause of death was cardiac in both groups (P=0.06). Conclusion: Acute myocardial infarction patients with a history of cancer were less likely to receive guideline recommended treatment and had worse inhospital outcomes than non-cancer patients.

[1]  G. Lip,et al.  2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). , 2016, European heart journal.

[2]  J. Dunning,et al.  Corrigendum to 'Statistical and data reporting guidelines for the European Journal of Cardio-Thoracic Surgery and the Interactive CardioVascular and Thoracic Surgery' [Eur J Cardiothorac Surg 2015;48:180-93]†. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  F. Eberli,et al.  Validity of Charlson Comorbidity Index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002–2012 , 2013, Heart.

[4]  Y. Kihara,et al.  Comparison of treatment and outcome of acute myocardial infarction between cancer patients and non-cancer patients. , 2013, International journal of cardiology.

[5]  R. Levin,et al.  Appropriateness of cardiovascular care in elderly adult cancer survivors , 2013, Medical Oncology.

[6]  G. Keel,et al.  Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? , 2013, Journal of Cancer Survivorship.

[7]  M. Lorez,et al.  Trends in Prostate Cancer Survival in Switzerland , 2013 .

[8]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[9]  F. Eberli,et al.  Temporal trends in treatment of ST-elevation myocardial infarction among men and women in Switzerland between 1997 and 2011 , 2012, European heart journal. Acute cardiovascular care.

[10]  J. Durand,et al.  Treatment and Outcomes of Acute Coronary Syndrome in the Cancer Population , 2012, Clinical cardiology.

[11]  Amir Y. Shaikh,et al.  Chemotherapy-Induced Cardiotoxicity , 2012, Current Heart Failure Reports.

[12]  A. Bordoni,et al.  Trends in Colorectal Cancer Survival in Switzerland , 2012 .

[13]  A. Bordoni,et al.  Trends in Lung Cancer Survival in Switzerland , 2012 .

[14]  Peter Jüni,et al.  An overview of the objectives of and the approaches to propensity score analyses. , 2011, European heart journal.

[15]  A. Bordoni,et al.  Trends in Breast Cancer Survival in Switzerland , 2011 .

[16]  Mats Lambe,et al.  Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  P. Erne,et al.  AMIS Plus: Swiss registry of acute coronary syndrome , 2010, Heart.

[18]  M. Maeng,et al.  Primary Angioplasty Versus Fibrinolysis in Acute Myocardial Infarction: Long-Term Follow-Up in the Danish Acute Myocardial Infarction 2 Trial , 2010, Circulation.

[19]  J. Lin,et al.  Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared With Controls: Changes from 1998 to 2002 , 2010 .

[20]  F. Eberli,et al.  Impact of comorbidities on clinical presentation, management and outcome of patients with acute coronary syndrome , 2010 .

[21]  Arnold Knijn,et al.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. , 2009, European journal of cancer.

[22]  C. Earle,et al.  Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  C. Earle,et al.  Preventive care for colorectal cancer survivors: a 5-year longitudinal study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  F. Eberli,et al.  Age‐Related Differences in the Use of Guideline‐Recommended Medical and Interventional Therapies for Acute Coronary Syndromes: A Cohort Study , 2008, Journal of the American Geriatrics Society.

[25]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[26]  P. Erne,et al.  Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry , 2007, Heart.

[27]  M. Balducci,et al.  Radiation-induced cardiovascular disease: impact of dose and volume. , 2005, Rays.

[28]  C. Earle,et al.  Under use of necessary care among cancer survivors , 2004, Cancer.

[29]  Michael C. Minnotte,et al.  Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[31]  Gwyn McClelland.  Survivors , 1891, The Hospital.